What were TTK Healthcare Ltd's latest quarterly results?
TTK Healthcare Ltd's latest quarterly results (Dec 2025) show
- PAT Growth YoY: -35.3%
- Revenue Growth YoY: +2.0%
- Operating Margin: 3.0%
TTK Healthcare Ltd (Pharma - Others) — fundamental analysis, earnings data, and key metrics. PE: 15.6. ROE: 6.9%. This stock is not currently in the Nifty 500 momentum outperformers list.
Based on publicly available financial data. This is educational research, not investment advice.
TTK Healthcare Ltd's latest quarterly results (Dec 2025) show
TTK Healthcare Ltd's current PE ratio is 15.6x.
TTK Healthcare Ltd's price-to-book ratio is 1.0x.
TTK Healthcare Ltd's fundamental strength based on key financial ratios
TTK Healthcare Ltd has a debt-to-equity ratio of N/A.
TTK Healthcare Ltd's return ratios over recent years
TTK Healthcare Ltd's operating cash flow is negative (FY2025).
TTK Healthcare Ltd's current dividend yield is 1.30%.
TTK Healthcare Ltd's shareholding pattern (Dec 2025)
TTK Healthcare Ltd's promoter holding has remained stable recently.
TTK Healthcare Ltd is an established outperformer with 1 weeks of consecutive Nifty 500 outperformance.
Based on quantitative research signals, here is why TTK Healthcare Ltd may be worth studying
TTK Healthcare Ltd investment thesis summary:
TTK Healthcare Ltd's forward outlook based on current data signals
The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.